EUVIMEDEUVIMED entdecken
Crossref

A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties

Tao Yu, Hongxia Pu, Xiaotong Chen, Qunshou Kong, Chong Chen, Gaocan Li, Qing Jiang, Yunbing Wang

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Tao Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials and College of Biomedical Engineering, Sichuan University, 29 Wangjiang Road, Chengdu 610064, C…. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Calcinosis, Heart Valve Diseases, Bioprosthesis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valvular heart disease is a major threat to human health and transcatheter heart valve replacement (THVR) has emerged as the primary treatment option for severe heart valve disease. Bioprosthetic heart valves (BHVs) with superior hemodynamic performance and compressibility have become the first choice for THVR, and more BHVs have been requested for clinical use in recent years. However, several drawbacks remain for the commercial BHVs cross-linked by glutaraldehyde, including calcification, thrombin, poor biocompatibility and difficulty in endothelialization, which would further reduce the BHVs' lifetime. This study developed a dual-functional non-glutaraldehyde crosslinking reagent OX-VI, which can provide BHV materials with reactive double bonds (CC) for further bio-function modification in addition to the crosslinking function. BHV material PBAF@OX-PP was developed from OX-VI treated porcine pericardium (PP) after the polymerization with 4-vinylbenzene boronic acid and the subsequent modification of poly (vinyl alcohol) and fucoidan. Based on the functional anti-coagulation and endothelialization strategy and dual-functional crosslinking reagent, PBAF@OX-PP has better anti-coagulation and anti-calcification properties, higher biocompatibility, and improved endothelial cells proliferation when compared to Glut-treated PP, as well as the satisfactory mechanical properties and enhanced resistance effect to enzymatic degradation, making it a promising candidate in the clinical application of BHVs. STATEMENT OF SIGNIFICANCE: Transcatheter heart valve replacement (THVR) has become the main solution for severe valvular heart disease. However, bioprosthetic heart valves (BHVs) used in THVR exhibit fatal drawbacks such as calcification, thrombin and difficulty for endothelialization, which are due to the glutaraldehyde crosslinking, resulting in a limited lifetime to 10-15 years. A new non-glutaraldehyde cross-linker OX-VI has been designed, which can not only show great crosslinking ability but also offer the BHVs with reactive double bonds (CC) for further bio-function modification. Based on the dual-functional crosslinking reagent OX-VI, a versatile modification strategy was developed and the BHV material (PBAF@OX-PP) has been developed and shows significantly enhanced anticoagulant, anti-calcification and endothelialization properties, making it a promising candidate in the clinical application of BHVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisCalcinosisHeart Valve DiseasesBioprosthesisSwineAnimalsHumansGlutaralAnticoagulantsEndothelial CellsThrombinHeart ValvesCross-Linking Reagents

Stichwörter der Autor:innen

Anti-calcification, Anti-coagulantCrosslinkingEndothelializationTranscatheter heart valve replacement

Substanzen

GlutaralAnticoagulantsThrombinCross-Linking Reagents

Autor:innen und Institutionen

  • National Engineering Research Center for Biomaterials and College of Biomedical Engineering, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China.
  • National Engineering Research Center for Biomaterials and College of Biomedical Engineering, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China. Electronic address: gaocanli@scu.edu.cn.
  • National Engineering Research Center for Biomaterials and College of Biomedical Engineering, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China. Electronic address: jiangq@scu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Meteorological Sciences
  • Science and Technology Department of Sichuan Province
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Sichuan Province Science and Technology Support Program
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Yu, T., Pu, H., Chen, X., Kong, Q., Chen, C., Li, G., Jiang, Q., & Wang, Y. (2023). A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.02.002

Vancouver

Yu T, Pu H, Chen X, Kong Q, Chen C, Li G, et al. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.02.002

BibTeX
@article{Yu2023,
  author = {Yu, Tao and Pu, Hongxia and Chen, Xiaotong and Kong, Qunshou and Chen, Chong and Li, Gaocan and Jiang, Qing and Wang, Yunbing},
  title = {A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.02.002}
}
Kostenlos starten →